Search Results - "Wang, Cathy S"

Refine Results
  1. 1
  2. 2

    Multiscale profiling of protease activity in cancer by Amini, Ava P., Kirkpatrick, Jesse D., Wang, Cathy S., Jaeger, Alex M., Su, Susan, Naranjo, Santiago, Zhong, Qian, Cabana, Christina M., Jacks, Tyler, Bhatia, Sangeeta N.

    Published in Nature communications (03-10-2022)
    “…Diverse processes in cancer are mediated by enzymes, which most proximally exert their function through their activity. High-fidelity methods to profile enzyme…”
    Get full text
    Journal Article
  3. 3

    Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma by Sanchez, Eric, Gillespie, Abigail, Tang, George, Ferros, Morgan, Harutyunyan, Nika Manik, Vardanyan, Suzie, Gottlieb, Jillian, Li, Mingjie, Wang, Cathy S, Chen, Haiming, Berenson, James R

    Published in Clinical cancer research (01-07-2016)
    “…Reduced uninvolved immunoglobulin (Ig) levels are a hallmark of multiple myeloma. We previously showed that B-cell maturation antigen (BCMA) is solubilized and…”
    Get full text
    Journal Article
  4. 4

    Aging and matrix viscoelasticity affect multiscale tendon properties and tendon derived cell behavior by Freedman, Benjamin R, Knecht, Raphael S, Tinguely, Yann, Eskibozkurt, G. Ege, Wang, Cathy S., Mooney, David J

    Published in Acta biomaterialia (15-04-2022)
    “…Aging is the largest risk factor for Achilles tendon associated disorders and rupture. Although Achilles tendon macroscale elastic properties are suggested to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma by Xu, Ning, Yu, Erin, Ng, Nicole, Li, Mingjie, Bujarski, Sean, Hekmati, Ava, Nassir, Isabella, Hekmati, Tara, Yu, Janna, Daniely, David, Wang, Cathy S., Kim, Clara, Chen, Haiming, Berenson, James R.

    Published in Hematological oncology (01-08-2023)
    “…We hypothesized that ruxolitinib may inhibit the immune checkpoint protein, B7H3; and, thus, investigated its effects on this immune inhibitor using multiple…”
    Get full text
    Journal Article
  10. 10

    The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker by Sanchez, Eric, Tanenbaum, Edward J, Patil, Saurabh, Li, Mingjie, Soof, Camilia M, Vidisheva, Aleksandra, Waterman, Gabriel N, Hekmati, Tara, Tang, George, Wang, Cathy S, Chen, Haiming, Berenson, James

    Published in Expert review of molecular diagnostics (03-04-2018)
    “…B-cell maturation antigen (BCMA) is a cell membrane bound tumor necrosis factor receptor family member that is expressed exclusively on late stage normal and…”
    Get more information
    Journal Article
  11. 11

    Anti-Angiogenic and Anti-Multiple Myeloma Effects of Oprozomib (OPZ) Alone and in Combination with Pomalidomide (Pom) and/or Dexamethasone (Dex) by Sanchez, Eric, Li, Mingjie, Wang, Cathy S, Tang, George, Gillespie, Abigail, Chen, Haiming, Berenson, James R

    Published in Leukemia research (01-06-2017)
    “…Highlights • Oprozomib (OPZ) shows anti-tumor activity in human multiple myeloma (MM) xenograft models • OPZ is an oral proteasome inhibitor that shows…”
    Get full text
    Journal Article
  12. 12

    Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects by Chen, Haiming, Li, Mingjie, Sanchez, Eric, Wang, Cathy S, Lee, Tiffany, Soof, Camilia M, Casas, Christian E, Cao, Jasmin, Xie, Colin, Udd, Kyle A, DeCorso, Kevin, Tang, George Y, Spektor, Tanya M, Berenson, James R

    Published in Molecular cancer research (01-05-2017)
    “…TNF receptor-associated factor 6 (TRAF6) has been implicated in polyubiquitin-mediated IL1R/TLR signaling through activation of kinase (IKK) to regulate the…”
    Get full text
    Journal Article
  13. 13

    Protease Activity Analysis: A Toolkit for Analyzing Enzyme Activity Data by Soleimany, Ava P., Martin-Alonso, Carmen, Anahtar, Melodi, Wang, Cathy S., Bhatia, Sangeeta N.

    Published in ACS omega (19-07-2022)
    “…Analyzing the activity of proteases and their substrates is critical to defining the biological functions of these enzymes and to designing new diagnostics and…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    A novel angiogenesis model for screening anti-angiogenic compounds: The chorioallantoic membrane/feather bud assay by HAIMING CHEN, WANG, Cathy S, BONAVIDA, Benjamin, BERENSON, James R, MINGJIE LI, SANCHEZ, Eric, LI, Jennifer, BERENSON, Ariana, WIRTSCHAFTER, Eric, WANG, James, JING SHEN, ZHIWEI LI

    Published in International journal of oncology (01-07-2010)
    “…Enhanced angiogenesis is a hallmark of solid tumors and hematological malignancies. Anti-angiogenic therapeutic approaches have recently been shown to be…”
    Get full text
    Journal Article
  17. 17

    Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth by Chen, Haiming, Gordon, Melinda S., Campbell, Richard A., Li, Mingjie, Wang, Cathy S., Lee, Hee Jin, Sanchez, Eric, Manyak, Steven J., Gui, Dorina, Shalitin, Dror, Said, Jonathan, Chang, Yunchao, Deuel, Thomas F., Baritaki, Stavroula, Bonavida, Benjamin, Berenson, James R.

    Published in Blood (01-07-2007)
    “…Pleiotrophin (PTN) is an important developmental cytokine that is highly expressed during embryogenesis but shows very limited expression in adult tissues,…”
    Get full text
    Journal Article
  18. 18

    Effects of INCB052793, a Selective JAK1 Inhibitor, in Combination with Anti-Myeloma Agents on Human Multiple Myeloma (MM) In Vitro and In Vivo by Sanchez, Eric, Li, Mingjie, Wang, Cathy S, Mehta, Puja, Tang, George, Chen, Haiming, Berenson, James

    Published in Blood (02-12-2016)
    “…Introduction: Several studies have demonstrated constitutive activation of the JAK-STAT pathway in MM through dysregulated signaling of cytokines such as IL-6…”
    Get full text
    Journal Article
  19. 19
  20. 20